Atlas Trials

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

Clinical trial NCT05628740 · COMPLETED

Trial details

NCT number
NCT05628740
Sponsor
Nocion Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Chronic Cough
Start date
2022-02-07
Primary completion
2022-10-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.